GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Dimed SA Distribuidora de Medicamentos (BSP:PNVL3) » Definitions » Price-to-Tangible-Book

Dimed Distribuidora de Medicamentos (BSP:PNVL3) Price-to-Tangible-Book : 1.39 (As of Jun. 06, 2024)


View and export this data going back to 1995. Start your Free Trial

What is Dimed Distribuidora de Medicamentos Price-to-Tangible-Book?

As of today (2024-06-06), Dimed Distribuidora de Medicamentos's share price is R$10.37. Dimed Distribuidora de Medicamentos's Tangible Book per Share of Mar. 2024 for the quarter that ended in Mar. 2024 was R$7.46. Hence, Dimed Distribuidora de Medicamentos's Price to Tangible Book Ratio of today is 1.39.

The historical rank and industry rank for Dimed Distribuidora de Medicamentos's Price-to-Tangible-Book or its related term are showing as below:

BSP:PNVL3' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 1.36   Med: 3.35   Max: 8.31
Current: 1.39

During the past 13 years, Dimed Distribuidora de Medicamentos's highest Price to Tangible Book Ratio was 8.31. The lowest was 1.36. And the median was 3.35.

BSP:PNVL3's Price-to-Tangible-Book is ranked better than
72.33% of 860 companies
in the Drug Manufacturers industry
Industry Median: 2.28 vs BSP:PNVL3: 1.39

A closely related ratio is called PB Ratio. As of today, Dimed Distribuidora de Medicamentos's share price is R$10.37. Dimed Distribuidora de Medicamentos's Book Value per Sharefor the quarter that ended in Mar. 2024 was R$8.04. Hence, Dimed Distribuidora de Medicamentos's P/B Ratio of today is 1.29.


Dimed Distribuidora de Medicamentos Price-to-Tangible-Book Historical Data

The historical data trend for Dimed Distribuidora de Medicamentos's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dimed Distribuidora de Medicamentos Price-to-Tangible-Book Chart

Dimed Distribuidora de Medicamentos Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Tangible-Book
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5.42 3.40 2.03 1.46 1.82

Dimed Distribuidora de Medicamentos Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Price-to-Tangible-Book Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.36 1.82 1.64 1.82 1.62

Competitive Comparison of Dimed Distribuidora de Medicamentos's Price-to-Tangible-Book

For the Drug Manufacturers - General subindustry, Dimed Distribuidora de Medicamentos's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Dimed Distribuidora de Medicamentos's Price-to-Tangible-Book Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Dimed Distribuidora de Medicamentos's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Dimed Distribuidora de Medicamentos's Price-to-Tangible-Book falls into.



Dimed Distribuidora de Medicamentos Price-to-Tangible-Book Calculation

Dimed Distribuidora de Medicamentos's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book=Share Price/Tangible Book per Share (Q: Mar. 2024 )
=10.37/7.461
=1.39

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.


Dimed Distribuidora de Medicamentos Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Dimed Distribuidora de Medicamentos's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.


Dimed Distribuidora de Medicamentos (BSP:PNVL3) Business Description

Traded in Other Exchanges
N/A
Address
Avenida Industrial Belgraf, 865, Eldorado do Sul, RS, BRA, 92990-000
Dimed SA Distribuidora de Medicamentos is engaged in the sale of medicines, perfumery, personal care and beauty products, cosmetics and dermocosmetics. Its segments are divided into Retail, Wholesale and Corporate. The Retail segment has 556 stores that sell more than 15,000 items among drugs and personal care and beauty products. The Wholesale segment is the distributor of drugs in Brazil. The Corporate segment includes Wholesale and Retail, as well as the subsidiary Lifar. In addition to adding divisions of cosmetics, drugs and food, Lifar is responsible for the production of brands in Brazil, as well as products of its own brand Panvel.

Dimed Distribuidora de Medicamentos (BSP:PNVL3) Headlines

No Headlines